Go to:
Logótipo
Você está em: Start > Publications > View > Expression and Clinical Relevance of SOX9 in Gastric Cancer
Map of Premises
Principal
Publication

Expression and Clinical Relevance of SOX9 in Gastric Cancer

Title
Expression and Clinical Relevance of SOX9 in Gastric Cancer
Type
Article in International Scientific Journal
Year
2019
Authors
Mesquita, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopes, N
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Gomes, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Azevedo, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Barros, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pereira, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cavadas, B
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Populo, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Boaventura, P
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
David L
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Pereira, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Raquel Almeida
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Title: Disease MarkersImported from Authenticus Search for Journal Publications
Vol. 2019
Pages: 1-11
ISSN: 0278-0240
Publisher: Hindawi
Other information
Authenticus ID: P-00Q-R8M
Abstract (EN): Gastric cancer is one of the most frequent tumours and the third leading cause of cancer-related death worldwide. The investigation of new biomarkers that can predict patient outcome more accurately and allow better treatment and follow-up decisions is of crucial importance. SOX9 (sex-determining region Y (SRY)-box 9) is a regulator of cell fate decisions in embryogenesis and adulthood. Here, we sought to ascertain the relevance of SOX9 transcription factor as a prognostic marker in gastric cancer. SOX9 expression was analyzed by immunohistochemistry in 333 gastric adenocarcinoma cases, and its association with clinicopathological and follow-up data was evaluated. SOX9 nuclear expression was absent in 17% of gastric cancer cases and predicted worse disease-free survival (P=0.03). SOX9 expression was associated with lower risk of relapse in Cox univariable analysis (HR=0.58; 95% CI=0.35-0.97; P=0.04). The prognostic value of SOX9 was more pronounced in tumours with expansive growth (P=0.01) or with venous invasion (P=0.02). Two validation cohorts from the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) confirmed that low SOX9 expression was significantly associated with poor patient outcome. In conclusion, we have identified SOX9 as a biomarker of disease relapse in gastric cancer patients. Further experiments are needed to elucidate its biological relevance at the cellular level.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The C677T polymorphism in MTHFR is not associated with migraine in Portugal (2008)
Article in International Scientific Journal
Ferro, A; Castro, MJ; Carolina Lemos; Santos, M; Alda Sousa; Pereira Monteiro, J; Sequeiros, J; Maciel, P
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study (2013)
Article in International Scientific Journal
Maria do Sameiro Faria; Sandra Ribeiro; Elisio Costa; Denisa Mendonca; Laetitia Teixeira; Petronila Rocha Pereira; Joao Fernandes; Henrique Nascimento; Michaela Kohlova; Flavio Reis; Leonilde Amado; Elsa Bronze da Rocha; Vasco Miranda; Alexandre Quintanilha; Luis Belo; Alice Santos Silva
Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma (2009)
Article in International Scientific Journal
Pinheiro, C; Longatto, A; Pereira, SMM; Etlinger, D; Moreira, MAR; Jube, LF; Queiroz, GS; Fernando Schmitt; Baltazar, F
Measurement of Cytokines and Adhesion Molecules in the First 72 Hours after Severe Trauma: Association with Severity and Outcome (2015)
Article in International Scientific Journal
Sousa, A; Raposo, F; Fonseca, S; Valente, L; Duarte, F; Goncalves, M; Tuna, D; Paiva, J-A

See all (9)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-22 at 10:21:55 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book